A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers

OBJECTIVE: The aim of this study was to evaluate whether a predictive model based on a contrast enhanced ultrasound (CEUS)-based nomogram and clinical features (Clin) could differentiate Her-2-overexpressing breast cancers from other breast cancers. METHODS: A total of 152 pathology-proven breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zi-mei, Wang, Ting-ting, Zhu, Jun-Yan, Xu, Yong-yuan, Chen, Fen, Huang, Pin-tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909531/
https://www.ncbi.nlm.nih.gov/pubmed/36776315
http://dx.doi.org/10.3389/fonc.2023.1035645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909531/
https://www.ncbi.nlm.nih.gov/pubmed/36776315
http://dx.doi.org/10.3389/fonc.2023.1035645

Ejemplares similares